[LXRX] YoY Quarter Result on 31-Mar-2016 [#Q1]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
05-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- -140.21%
YoY- -24.24%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Revenue 9,216 25,207 18,293 12,494 1,792 277 360 71.63%
PBT -21,797 -42,075 -43,543 -34,883 -28,076 -30,835 -25,974 -2.87%
Tax 789 6,119 -8,652 1,128 1,347 543 540 6.52%
NP -21,797 -42,075 -34,891 -34,883 -28,076 -30,835 -25,974 -2.87%
Tax Rate - - - - - - - -
Total Cost 31,013 67,282 53,184 47,377 29,868 31,112 26,334 2.76%
Ratio Analysis
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
NP Margin -236.51 -166.92 -190.73 -279.20 -1,566.74 -11,131.77 -7,215.00 -43.41%
Per Share
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
EPS -0.21 -0.40 -0.33 -0.34 -0.27 -0.42 -0.35 -8.15%
EPS Diluted -0.21 -0.40 -0.33 -0.34 -0.27 -0.42 -0.35 -8.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.